Navigation Links
Millennium Laboratories Founder and CEO James Slattery Named Ernst & Young Entrepreneur Of The Year® 2011 Award Semifinalist in San Diego
Date:4/25/2011

SAN DIEGO, April 25, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of prescription drug monitoring services and education to physicians and staff treating chronic pain, announced today that the company's founder and CEO James Slattery has been named as a semifinalist for the Ernst & Young Entrepreneur Of The Year® 2011 Award for the San Diego region. Slattery was selected as a semifinalist from nearly 165 nominations by a panel of independent judges. The Ernst & Young awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Award winners will be announced on June 16, 2011.

(Photo: http://photos.prnewswire.com/prnh/20110425/LA88476)

James Slattery launched Millennium Laboratories in late 2006 after a successful career that encompassed broadcast communications and real estate development.  Under his direction as chief executive officer in less than five years the company has built a solid reputation as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education.  A national network of physicians now uses Millennium Laboratories' services to increase patient safety and improve patient care for people experiencing chronic pain.

Millennium Laboratories is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy. In 2010 the company established the Millennium Research Institute, a national, non-profit center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders.

Millennium CEO James Slattery noted, "I am honored to have been selected as a semifinalist for the prestigious Ernst & Young Entrepreneur Of The Year award program. As a values-based organization, Millennium Laboratories places the needs of our physician network and their patients first. This is the cornerstone of our success and our reputation. The Ernst & Young acknowledgement is a direct outgrowth of the hard work, integrity and commitment to excellence of everyone on the Millennium team in establishing the gold standard in prescription drug monitoring."

The Ernst & Young Entrepreneur Of The Year awards program celebrates its 25th anniversary this year. The program has expanded to recognize business leaders in over 140 cities and over 50 countries throughout the world.

Regional award winners are eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 12, 2011. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation's most prestigious gathering of high-growth, market-leading companies, and is held from November 9-13, 2011.

About Millennium Laboratories

Located in San Diego's life sciences cluster, Millennium Laboratories, Inc. is a national, research-based medication monitoring company whose test offerings, technology, customer support, educational resources and experts are specifically focused on clinicians who treat chronic pain. The company is recognized as a leader in pain management services, setting industry standards in drug testing and reporting, clinical research and education. Millennium serves as an industry, government and payer educator and a compassionate advocate for pain sufferers throughout the United States. The company is accredited by The Joint Commission, receiving the Gold Seal of Approval™ for healthcare quality and safety.  

Among the numerous scientific and research achievements of the company's renowned laboratory team, Millennium Laboratories is certified as a training facility for clinical toxicologist scientists and operates as a unique research component of the University of California, San Diego's (UCSD) doctoral program in Pharmacy.

As part of the company's commitment to pain management research and education, Millennium Laboratories established the Millennium Research Institute (MRI), a non-profit, national research center that conducts and disseminates original research focused on improving the experiences of people suffering from pain and pain-related disorders. MRI maintains several national academic partnerships and supports collaborative research by accessing Millennium Laboratories' unique database representing the U.S. pain population.  For more information, visit the Millennium Laboratories website, www.becausepainmatters.com.

About Ernst & Young's Entrepreneur Of The Year® Awards Program

Ernst & Young's Entrepreneur Of The Year® is the world's most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year® celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited located in the U.S.


'/>"/>
SOURCE Millennium Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
2. Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkins Lymphoma
3. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
4. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
5. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
6. $500 Billion Health Care Spend Boosts BRIC Countries Diagnostic Imaging Sales Despite Global Recession, According to Millennium Research Group
7. Global Spinal Nonfusion Market to Reach Almost $2 Billion By 2013, According to Millennium Research Group
8. Millennium Pharmacy Adds First Client in New England
9. Reprocessed Catheters: A Growing Force In the US Electrophysiology Diagnostic Catheter Market, According to Millennium Research Group
10. Major Health Care Reforms in China Supported Growth of More Than 20% in the Drug-Eluting Stent Market in 2009, According to Millennium Research Group
11. Millennium Pharmacy Expands in New Jersey
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  Venice,s newest ... is the first of its kind in the ... tattoos through advanced laser treatment. The physician-owned and ... Suncoast by storm with its revitalizing ... and advanced multi-wavelength Astanza Trinity technology. ...
(Date:2/5/2016)... India , February 5, 2016 ... a new market research report "Fetal (Labor & Delivery) ... & Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy/Jaundice Management Devices, ... published by MarketsandMarkets, This report studies the global market ... market is estimated at USD 6.28 Billion in 2015 ...
(Date:2/5/2016)... Feb. 5, 2016 ... the "Global Obstetrics Partnering 2010-2016: Deal ... to their offering. --> http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ... "Global Obstetrics Partnering 2010-2016: Deal trends, ... their offering. --> Research and ...
Breaking Medicine Technology:
(Date:2/5/2016)... , ... February 05, 2016 , ... ... President George H. Van Allen have signed a joint enrollment and degree completion ... seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The agreement ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... The American ... technology, such water may be safer than regular municipal or well water. The recent ... radio host Sharon Kleyne, could go a long way toward increasing public acceptance of ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
(Date:2/5/2016)... ... 05, 2016 , ... In sleep, when the defenses of the day are ... of patients with eating disorders is significant self-criticism, and consequently these patients experience this ... regarded as maladaptive means for coping with this unease, but also leads to a ...
(Date:2/5/2016)... , ... February 05, 2016 , ... ... Columbia University Men’s Soccer Career Development event in New York City on Thursday, ... Commisso, Chairman and CEO of Mediacom, (both alumnus of the varsity Columbia soccer ...
Breaking Medicine News(10 mins):